Stock Picks

Mar. 22, 2026

Sound View Wealth Advisors Group LLC Decreases Bristol Myers Squibb Stake

Biopharmaceutical firm's shares owned by advisory firm down 14% in Q4 2025

Mar. 22, 2026

Great Oak Capital Partners Boosts Johnson & Johnson Holdings

Institutional investor increases stake in healthcare giant by over 300%

Mar. 21, 2026

Union Bancaire Privee UBP SA Increases Johnson & Johnson Holdings

The Swiss private bank's stake in the healthcare giant grew by 3.4% in the fourth quarter.

Mar. 21, 2026

IAM Advisory LLC Boosts Bristol Myers Squibb Stake

Institutional investor increases position in pharmaceutical company by $1.66 million

Mar. 21, 2026

MFG Wealth Management Inc. Acquires 20,156 Shares of Bristol Myers Squibb

The investment firm added a new stake in the biopharmaceutical company's stock in Q4 2025.

Mar. 21, 2026

Park National Corp OH Boosts Johnson & Johnson Stock Holdings

Institutional investor increases stake in pharmaceutical giant by 24.3% in Q4 2025

Mar. 21, 2026

AIA Group Boosts Stake in Johnson & Johnson

Institutional investor increases holdings in pharmaceutical giant by 70.5% in Q3

Mar. 21, 2026

Swiss Life Asset Management Trims Johnson & Johnson Stake

Institutional investor reduces holdings in healthcare giant by 2%

Mar. 19, 2026

Wilmington Savings Fund Society FSB Reduces Bristol Myers Squibb Holdings

The fund decreased its stake in the biopharmaceutical company by 20.8% in the third quarter.

Mar. 19, 2026

Opes Wealth Management Reduces Johnson & Johnson Holdings

Firm sells over 5,000 shares of healthcare giant in Q3

Mar. 17, 2026

London Co. of Virginia Sells 42,828 Shares of Johnson & Johnson

Firm reduces stake in pharmaceutical giant by 2.4% in Q3

Mar. 17, 2026

Bank of Nova Scotia Increases Bristol Myers Squibb Stake

The Canadian bank grew its holdings in the biopharmaceutical company by 41.9% in the third quarter.

Mar. 16, 2026

HighVista Strategies Invests $1.39M in ADMA Biologics

Biotechnology firm ADMA Biologics sees new investment from HighVista Strategies

Mar. 16, 2026

Granahan Investment Management Reduces Stake in Bel Fuse Inc.

The investment firm sold over 21,000 shares of the electronics manufacturer in Q3 2025.

Mar. 16, 2026

BNP Paribas Reduces Bristol Myers Squibb Stake

Institutional investor trims holdings in pharmaceutical company

Mar. 16, 2026

Hamilton Wealth LLC Boosts Bristol Myers Squibb Stake

Investment firm increases holding in biopharmaceutical company by over 150%

Mar. 16, 2026

Capitolis Liquid Global Markets Reduces Bristol Myers Squibb Stake

Hedge fund cuts holdings in pharmaceutical company by over 78% in Q3

Mar. 15, 2026

Cannell & Spears LLC Reduces Bristol Myers Squibb Holdings

Institutional investor cuts stake in pharmaceutical company by 6.7%

Mar. 15, 2026

Bank of Nova Scotia Grows Position in Johnson & Johnson

The Canadian bank increased its stake in the pharmaceutical giant by over 100% in the third quarter.

Mar. 15, 2026

Banco Bilbao Vizcaya Argentaria S.A. Increases Bristol Myers Squibb Stake

The Spanish bank now owns over $29 million in shares of the biopharmaceutical company.